Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when the company’s generic business continues to face pricing ...

Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food and Drug Administration for a host of serious manufacturing violations at a key plant in India ...

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

The Food and Drug Administration is continuing its use of import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.

According to an ETNow poll, the drugmakers consolidated revenue for the quarter ended December is seen rising 12.5% on-year to Rs 11,100 crore ...

iBeat Analytics Ibeat 1 Year HTTPS To track article's statistics The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate ...

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

The companies have executed a definitive agreement under which Sun Pharma will acquire all outstanding shares of Concert ...

(Reuters) -Sun Pharmaceutical Industries Limited said on Thursday it will acquire U.S.-based Concert Pharmaceuticals for $576 ...